Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma)

Dijana Celić, Jasna Lipozenčić, Branko Kolarić, Goran Ferenčak, Jolanda Kanižaj Rajković and Tajana Borlinić
Additional contact information
Dijana Celić: Medikol Polyclinic, Franca Prešerna 13, 40 000 Čakovec, Croatia
Jasna Lipozenčić: Croatian Academy of Medical Sciences, Praška 2, 10 000 Zagreb, Croatia
Branko Kolarić: Faculty of Medicine, University of Rijeka, Braće Branchetta 20/1, 51 000 Rijeka, Croatia
Goran Ferenčak: Medikol Polyclinic, Franca Prešerna 13, 40 000 Čakovec, Croatia
Jolanda Kanižaj Rajković: Medikol Polyclinic, Franca Prešerna 13, 40 000 Čakovec, Croatia
Tajana Borlinić: Čakovec County Hospital, Ivana Gorana Kovačića 1E, 40 000 Čakovec, Croatia

IJERPH, 2019, vol. 16, issue 13, 1-10

Abstract: Background: Development of nonmelanoma skin cancers (NMSCs) has been associated with certain risk factors, but studies of the association between ABO blood group and NMSCs have been rare and inconclusive. The aim of this study was to assess the association of the previously known risk factors and blood group as a new potential risk factor in NMSCs. Methods: The study included 401 patients, 202 men, and 199 women, which included 367 diagnosed cases of basal cell carcinoma and 148 diagnosed cases of squamous cell carcinoma. The control group consisted of 438 subjects, 198 men, and 240 women. A standardized questionnaire adapted for this targeted study was used. The relation between the dependent variable (NMSCs) and independent variables was investigated by logistic regression. Results: Compared to the non AB blood group, the risk of developing NMSCs was significantly higher in the AB blood group (MOR = 2.28; 95% CI = 1.41–3.69). We established a logistic model that could best describe the probability of NMSCs development. Conclusion: Study results are expected to instigate basic research into the role of A and B antigens in normal skin epithelium, NMSCs etiopathogenesis, possible effect on metastatic potential and disease prognosis, potential tumor immunotherapy, and targeted detection and prevention in subjects at an increased risk of NMSCs development.

Keywords: ABO blood groups; nonmelanoma skin cancers; basal cell carcinoma; squamous cell carcinoma (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/16/13/2267/pdf (application/pdf)
https://www.mdpi.com/1660-4601/16/13/2267/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:16:y:2019:i:13:p:2267-:d:243333

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().